Drugs with this side effect
- 1,25(OH)2D3
- 17-hydroxyprogesterone: postmarketing
- 18F-FDG
- 2-hydroxysuccinaldehyde: 2% - 19%
- 4-AP
- 4-PBA: common
- 4-methylpyrazole
- 5-ASA: postmarketing, common, 1% - 23%
- 5-FU
- 5-aminolevulinic acid
- 5-aza-2'-deoxycytidine: 8.64% - 19.3%
- 5-azacytidine: common, very common, 0% - 14.1%
- 5-fluorocytosine
- 6-mercaptopurine
- 68Ga
- 8-MOP: postmarketing
- A77 1726: 5.31%
- ACTH(1-39: 0%
- AMD3100
- APAs
- Almeta
- Anidulafungin: 0.664% - 1.5%
- Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2
- Azarga
- BCNU: 2% - 11.7%
- BPTI
- Benicar-HCT
- Bivalirudin: postmarketing
- Buscopan
- CAS 1405-87-4
- CAS 76095-16-4: 1.3% - 1.4%
- CAS 76420-72-9
- CGP 19835A: common
- Cancidas: 0% - 23%
- Colimycin M
- D-cycloserine
- D-penicillamine: 5%
- DFMO: 0% - 2.8%
- Diane-35
- EACA
- EDTA
- Enfuvirtide
- Eptifibatide: very rare, postmarketing
- Estrofem
- FAMP
- FK463: 1.79% - 30.2%
- FdUrd
- Fe(III
- Forteo: 4.9%
- Gd-DTPA
- Gd-EOB-DTPA
- Ge-132: 14%
- Glat copolymer
- Goserelin: 1% - 8%
- Hoe 140
- Humalog
- ICI 182,780: postmarketing, 7.3% - 8%
- Implanon: postmarketing
- Insulin
- K779: 1% - 34%
- Kaluril
- L-Dmp
- LY146032: postmarketing, common, 2.5% - 8.62%
- Lantus
- Leuprorelin: postmarketing, 3%
- LiOH
- Lisinopril: postmarketing, uncommon, 1% - 5%
- Locorten Vioform
- Lovaza: 1.8%
- Lutalyse
- MK-462: postmarketing
- Madopar
- Meropenem anhydrous: 1.9%
- Mersyndol
- Metrodin: postmarketing, 2.67% - 3.33%
- MnDPDP
- N-acetylcysteine: 4.23%
- N-carbamylglutamate
- NSC 352122
- Nafarelin
- NovoLog: very rare, uncommon
- NuvaRing
- Nuvocid
- Octreotide: common
- Oestrogen: uncommon, 3% - 6%
- Optison: postmarketing, rare
- Org 37462: very rare
- PCI-32765: 0% - 24%
- PGE1: 1% - 11%
- PGE2
- Paroven
- Photofrin: 4.35% - 7.07%
- Photofrin II: common
- Prednefrin
- Promacta
- Refludan: 1%
- Revasc
- S-benzoylmercaptoacetyltriglycine
- SU5416
- Saxagliptin
- SonoVue
- Stalevo 50
- Supremon
- T-A2-3
- TMC207: 7.59%
- TMC435: 15% - 27.9%
- TPGS
- Tadenan: 0.5%
- Timentin
- TlCl
- Triphasil
- Triptorelin: 1.7%
- Trisequens
- UDCA: postmarketing
- VACV: postmarketing, uncommon, 1% - 14%
- Vallergan
- Vancocine: postmarketing
- Vitrum: 0.102%
- Westcort
- Zyprexa Relprevv: rare
- abacavir: very rare, common, 4.82% - 68%
- abacavir-lamivudine: postmarketing, common
- abiraterone: 0%
- acamprosate: frequent
- acarbose: postmarketing
- acebutolol: 1% - 4%
- acetaminophen: postmarketing
- acetohydroxamic acid
- acipimox
- acitretin: postmarketing
- acyclovir: postmarketing, common, 1.3% - 1.7%
- adapalene
- adefovir
- adefovir dipivoxil: postmarketing, common
- adenosine: postmarketing
- afatinib: very common, 0% - 90%
- albendazole: postmarketing
- alclometasone
- alendronate: postmarketing
- alfentanil
- alfuzosin: postmarketing, uncommon
- aliskiren: uncommon
- allopurinol: 1.5%
- almotriptan: infrequent
- alogliptin: postmarketing
- alosetron: postmarketing
- alprazolam: infrequent, 8.1% - 11%
- amantadine: rare
- ambrisentan: postmarketing, uncommon
- amifostine
- amikacin
- amiloride
- aminoglutethimide
- aminophylline
- amiodarone
- amitriptyline
- amlodipine
- amlodipine besylate
- ammonium lactate
- amobarbital
- amoxapine
- amoxicillin: postmarketing, common
- amphetamine
- amphotericin B: 4.6% - 24.8%
- ampicillin
- amprenavir: very common, 2% - 20%
- amsacrine
- anagrelide: 8%
- anastrozole: postmarketing, 5.73% - 12.5%
- anthracycline
- apixaban: uncommon
- apremilast
- aprepitant: postmarketing
- argatroban: 2% - 7%
- arginine
- aripiprazole: 2% - 6%
- arsenic
- arsenic trioxide
- asenapine
- aspirin
- atazanavir: postmarketing, common, 9% - 14%
- atenolol: postmarketing
- atomoxetine: common, 2%
- atorvastatin: postmarketing, 1.1% - 3.9%
- atosiban
- atovaquone: 4% - 46%
- atracurium
- atropine: rare
- auranofin: postmarketing, 24% - 39%
- avanafil
- axitinib: 1% - 32%
- azathioprine
- azelaic acid
- azelastine: postmarketing
- azilsartan: postmarketing
- azilsartan medoxomil
- azithromycin: postmarketing, 3.4% - 9.4%
- aztreonam: 2% - 4.3%
- baclofen: common
- balsalazide
- bazedoxifene
- beclomethasone: postmarketing
- beclomethasone dipropionate
- beclomethasone monopropionate
- belinostat: 1% - 20%
- benazepril
- benazeprilat
- bendamustine: 2.1% - 7.84%
- bendrofluazide
- benzocaine
- benztropine
- benzyl alcohol
- bepotastine: postmarketing
- bepridil
- betahistine
- betaxolol: postmarketing, 0% - 1.2%
- bexarotene: very common, 0% - 78%
- bezafibrate: 4% - 14%
- bicalutamide: 6% - 9%
- bicarbonate
- bimatoprost: postmarketing
- bisoprolol: very rare, postmarketing, rare
- bleomycin hydrochloride
- boceprevir: very common, 5% - 19%
- bortezomib: 0% - 27.7%
- bosentan: postmarketing, uncommon
- bosutinib: 6.1% - 35%
- brimonidine: postmarketing
- brinzolamide: postmarketing
- bromazepam: postmarketing
- bromcresol green: 1% - 7%
- bromhexine
- bromocriptine
- budesonide: postmarketing, 1% - 4.1%
- bumetanide: 0.2%
- buprenorphine: 2%
- bupropion: postmarketing, frequent, 0.8% - 8%
- buspirone: 1%
- busulfan: 50% - 67%
- butabarbital
- butorphanol: infrequent
- cabergoline: postmarketing
- cabozantinib: 0% - 19%
- caffeine: 8.7%
- calcipotriol
- canagliflozin: uncommon
- candesartan: postmarketing
- candesartan cilexetil: postmarketing
- capecitabine: 6% - 8%
- capreomycin
- captopril: postmarketing
- carbamazepine: rare, very common, 7% - 13%
- carbenicillin
- carbidopa
- carbimazole
- carboplatin
- carboprost
- carnitine: 3% - 5%
- carvedilol
- cefaclor
- cefadroxil
- cefazolin: postmarketing
- cefdinir
- cefditoren
- cefepime: 1.1% - 4%
- cefixime: postmarketing
- cefotaxime
- cefotetan
- cefoxitin
- cefpodoxime
- cefprozil: 0.9% - 1.2%
- ceftaroline: 2% - 3%
- ceftazidime
- ceftizoxime
- ceftobiprole: 0.6% - 0.9%
- ceftriaxone: postmarketing, 1.3% - 1.7%
- cefuroxime: postmarketing
- cefuroxime axetil
- celecoxib: 1.2% - 2.2%
- celiprolol
- cephalexin
- cephem
- cerivastatin: 3%
- cetirizine: postmarketing
- cetrorelix
- cevimeline: 4.3%
- chloramphenicol
- chloride
- chlorthalidone: common
- chlorzoxazone
- choline theophyllinate
- ciclesonide: 0.1%
- ciclopirox: postmarketing
- cidofovir: postmarketing, very common, 29.6%
- cilazapril: postmarketing
- cilostazol
- cimetidine: common, 1.2%
- cinacalcet: postmarketing, common
- cinoxacin
- ciprofloxacin: postmarketing, rare, uncommon, 1% - 1.8%
- cisatracurium: 0.1%
- cisplatin
- citalopram: infrequent, uncommon, frequent, 1%
- cladribine: very common, 10% - 27%
- clarithromycin: postmarketing, common, 2.2% - 3%
- clindamycin: postmarketing, 7%
- clindamycin phosphate
- clobazam: postmarketing, 1.4%
- clobetasol: postmarketing
- clobetasone butyrate: very rare
- clodronate
- clofarabine: 21%
- clofazimine
- clomiphene citrate
- clomipramine: rare, common, 4% - 8%
- clonazepam
- clonidine: 0% - 2%
- clopidogrel: uncommon
- clorazepate
- clotrimazole
- clozapine: 2%
- cobicistat: common
- codeine
- colchicine: postmarketing
- colesevelam
- colestimide: uncommon
- colestipol
- colestyramine
- conjugated estrogens: postmarketing
- copolymer 1
- cortisol: postmarketing
- cosyntropin
- crizotinib: 0% - 9%
- crotamiton
- cyanocobalamin
- cyclobenzaprine
- cyclopentolate
- cyclophosphamide
- cyproheptadine
- cyproterone
- cyproterone acetate: very rare, rare, uncommon
- cysteamine: common, 7%
- cytarabine
- d-telaprevir: very common, 34%
- dabigatran
- dabigatran etexilate: uncommon
- dabrafenib: very common, 0% - 53%
- dacarbazine
- dalbavancin: 2.45% - 2.7%
- dalteparin: 1.16% - 1.53%
- danazol: 3%
- dantrolene
- dapagliflozin: 0.2%
- darifenacin
- darunavir: 5% - 19%
- dasatinib: 0% - 21%
- deferasirox: common, 1.54% - 13.2%
- deferiprone: postmarketing
- degarelix
- delamanid
- delavirdine: 0% - 35.4%
- delta 9-THC
- demeclocycline
- demethyl
- deprenyl: 4%
- desipramine
- desloratadine: postmarketing
- desmopressin
- desogestrel
- desonide
- desvenlafaxine: 1% - 2%
- dexamethasone
- dexmedetomidine
- dextrorphan
- diatrizoate
- diazepam
- diazoxide
- diclofenac: postmarketing, infrequent, common, 0% - 46%
- dicloxacillin: common
- dicyclomine: postmarketing
- didanosine: 5% - 9%
- diethylpropion
- diflunisal
- digoxin: 1.63% - 2%
- dihydrocodeine: uncommon
- dihydroergotamine: postmarketing, infrequent
- diltiazem: postmarketing, 0% - 2.04%
- dimenhydrinate
- dimercaptosuccinic acid
- dipyridamole: 2.3%
- disopyramide
- docetaxel: 0% - 25.9%
- dofetilide: 3%
- dolasetron
- dolutegravir: 0% - 6%
- domperidone
- donepezil: postmarketing, frequent
- doripenem: common, 0.2% - 6%
- dorzolamide
- dothiepin
- doxazosin: postmarketing, 1% - 1.7%
- doxepin: rare
- doxorubicin: postmarketing, common, very common, 0% - 28.5%
- doxycycline: postmarketing, 3.76%
- doxycycline calcium
- doxycycline hyclate: 3.76%
- dronedarone: 5%
- droperidol
- duloxetine: postmarketing, rare, frequent, 4%
- dutasteride: postmarketing
- efavirenz: very common, 0% - 46%
- eletriptan: infrequent
- eliglustat: 0% - 4.72%
- eltrombopag: 3%
- elvitegravir: common
- emedastine
- emtricitabine: postmarketing, common, 9% - 21%
- entacapone
- entecavir: postmarketing, uncommon
- ephedrine
- eplerenone: postmarketing
- eprosartan
- eribulin
- erlotinib: 0% - 85%
- ertapenem: 1% - 8.3%
- erythromycin lactobionate
- eslicarbazepine: 1%
- eslicarbazepine acetate
- esomeprazole magnesium
- estazolam: infrequent
- estradiol: postmarketing, common, 2.87% - 8.89%
- estradiol cypionate
- estradiol valerate
- estramustine: 1% - 4%
- estramustine phosphate
- estrone
- ethacrynic acid
- ethambutol
- ethionamide
- ethosuximide
- ethotoin
- etidronate: postmarketing
- etodolac
- etoposide
- etoposide phosphate
- etoricoxib: postmarketing
- etravirine: 9% - 17%
- everolimus: common, very common, 0% - 59%
- exemestane: common, 0% - 2-5%
- ezetimibe: postmarketing
- famciclovir: very rare, postmarketing, common, 0% - 3.3%
- famotidine: 1.2%
- febuxostat: 0.5% - 1.6%
- felbamate: 0% - 9.7%
- felodipine
- fenofibrate: uncommon, 1.5% - 2.31%
- fenoprofen
- fentanyl: very rare, postmarketing, common, 0% - 8%
- ferumoxytol: postmarketing, 0.4% - 1%
- fesoterodine: 0.7% - 1.1%
- fexofenadine: postmarketing
- fidaxomicin: postmarketing
- finasteride: postmarketing, 0.5%
- flecainide
- flucloxacillin: uncommon
- fluconazole: 1.8%
- fludarabine: 4% - 15%
- flumazenil
- flunisolide: 1.8% - 3.7%
- flunitrazepam: uncommon
- fluocinolone acetonide
- fluocinonide: postmarketing
- fluorescein: postmarketing
- fluorometholone
- fluoxetine: common, 1% - 6.4%
- flurazepam
- flurbiprofen
- flutamide: 8%
- fluticasone: postmarketing, 0.452% - 1.38%
- fluticasone furoate: postmarketing
- fluticasone propionate: very rare, postmarketing, 0.2% - 1%
- fluvastatin: postmarketing, rare, 0.2% - 1.9%
- fluvoxamine: infrequent, uncommon
- folate
- fondaparinux: uncommon, 7.5% - 8.32%
- formoterol: postmarketing, rare, 1.1% - 4%
- fosamprenavir: rare, common
- fosaprepitant
- fosaprepitant dimeglumine: postmarketing
- foscarnet
- fosfomycin
- fosfomycin trometamol
- fosinopril: 1% - 1.4%
- fosinoprilat
- fosphenytoin: frequent
- furosemide
- fusidic acid
- gabapentin: postmarketing, 0.9% - 1.5%
- gadobenate dimeglumine: postmarketing
- gadobutrol: 0.3%
- gadodiamide
- gadofosveset
- gadolinium: 0.3%
- gadopentetate: postmarketing
- gadoteridol: 0.17%
- gadoversetamide: 0.361% - 2.13%
- galantamine
- ganciclovir
- gatifloxacin
- gefitinib: very common, 0% - 68.9%
- gemcitabine: 0% - 30%
- gemfibrozil: 1.3% - 2.5%
- gemifloxacin: postmarketing, 0.3% - 2.8%
- gentamicin
- glibenclamide
- gliclazide: 1% - 1.2%
- glimepiride
- glipizide
- glutamine: 0% - 12.5%
- glycerol phenylbutyrate
- glycopyrrolate: uncommon
- gold sodium thiomalate: 30%
- granisetron: 1%
- griseofulvin
- guaifenesin
- guanfacine: postmarketing
- guanidinium
- halobetasol
- halofantrine
- haloperidol: very rare, postmarketing
- hepatitis B vaccines: rare
- hetastarch: postmarketing
- histamine
- homatropine
- hydralazine: uncommon
- hydrochlorothiazide: 1.4%
- hydrocodone
- hydroflumethiazide
- hydromorphone: 2.59%
- hydroxocobalamin
- hydroxybutyrate
- hydroxychloroquine
- hydroxyurea: uncommon
- hydroxyzine
- ibandronate: postmarketing, 1.3% - 3%
- ibuprofen
- icodextrin: postmarketing, 5% - 10%
- idarubicin
- ifosfamide: postmarketing
- iloperidone: 2% - 3%
- iloprost: postmarketing
- imatinib: very common, 0% - 53%
- imipramine: common
- imiquimod: uncommon, 0.1% - 1.1%
- indacaterol: postmarketing, uncommon
- indapamide
- indinavir: postmarketing, 1.2% - 19.1%
- indomethacin: 1% - 2%
- insulin detemir
- iodide
- iodixanol: 6.1%
- iohexol
- iopamidol
- iopromide: postmarketing
- ioversol
- ioxilan
- ipratropium bromide: postmarketing, uncommon
- irbesartan: postmarketing, 1.3%
- irbesartan-hydrochlorothiazide
- irinotecan: 0% - 46.1%
- iron sucrose
- isoflurane
- isomannide
- isosorbide dinitrate
- isosorbide-5-mononitrate
- isoxsuprine
- isradipine: 0.7% - 1.5%
- itraconazole: postmarketing, 1% - 9%
- ivabradine
- ivacaftor: 10% - 12.8%
- ivermectin: 1% - 0.9%
- ixabepilone: 0% - 9%
- kanamycin
- ketamine
- ketoconazole: postmarketing
- ketoprofen
- ketorolac: 3%
- ketorolac tromethamine: postmarketing
- ketotifen
- labetalol: 0% - 1%
- lacosamide: postmarketing
- lactate
- lamivudine: postmarketing, common, 1% - 14%
- lamotrigine: 3% - 14%
- lansoprazole: 1.15% - 3.23%
- lapatinib: very common, 0% - 24%
- latanoprost: 0% - 1.5%
- leflunomide: postmarketing, common, 7% - 12%
- lenalidomide: postmarketing, uncommon, very common, 1.49% - 37.8%
- lercanidipine: rare, common
- letrozole: common, 3% - 12%
- leucovorin: postmarketing
- leuprorelin acetate
- levetiracetam: 0% - 2.8%
- levocabastine
- levodopa/carbidopa
- levonorgestrel: postmarketing
- lidocaine
- linaclotide
- linagliptin: postmarketing
- lincomycin
- linezolid: 0.4% - 15.2%
- liraglutide: postmarketing
- lisdexamfetamine dimesylate: postmarketing, 3%
- lithium
- lithium carbonate
- lodoxamide
- lodoxamide tromethamine
- lomefloxacin
- loperamide: postmarketing
- loratadine
- lorazepam
- lorcaserin: 2.1%
- lormetazepam
- losartan
- lovastatin: 0.8% - 1.3%
- loxapine
- lubiprostone: postmarketing
- lurasidone: frequent
- mafenide acetate: 4.6%
- malvidin
- mannitol
- maprotiline
- maraviroc: 5% - 11%
- mebendazole
- mebeverine
- mebrofenin
- medroxyprogesterone: 1.1%
- medroxyprogesterone acetate: 1%
- mefenamic acid
- mefloquine: postmarketing
- megestrol: 2% - 12%
- megestrol acetate
- melatonin
- meloxicam: 0% - 3.8%
- melphalan: rare
- memantine: postmarketing, frequent
- meperidine
- mephenytoin
- meropenem: 1.1% - 1.9%
- mesna
- metaiodobenzylguanidine
- metaxalone
- metformin: very rare, common
- methadone
- methazolamide
- methenamine hippurate
- methenamine silver
- methimazole
- methocarbamol
- methotrexate: 1-10%
- methsuximide
- methyclothiazide
- methyl aminolevulinate
- methyldopa
- methylene blue
- methylene diphosphonate
- methylergometrine
- methylphenidate: postmarketing, common, 1.3% - 2%
- methylprednisolone
- methylprednisolone sodium succinate
- methysergide
- metipranolol
- metoclopramide: postmarketing
- metolazone
- metoprolol: rare, uncommon, common
- metronidazole: very rare, postmarketing, 1%
- mexiletine: 1.4% - 10.3%
- mianserin
- miconazole
- midazolam: uncommon, 1% - 2%
- midodrine: 1.1% - 2.4%
- mifepristone
- miglitol
- milnacipran: 2% - 4%
- milrinone: postmarketing
- minocycline: 0% - 1.2%
- minoxidil
- mirabegron
- mirtazapine: postmarketing, frequent
- misoprostol: postmarketing
- mitomycin C
- mitotane
- mitoxantrone
- mivacurium
- moclobemide
- modafinil: postmarketing, 1% - 4%
- moexiprilat: 1.63%
- molindone
- mometasone: postmarketing
- monomethylfumarate: 8%
- montelukast: postmarketing, 1.6%
- morphine: postmarketing, 3%
- moxifloxacin: 0.5%
- moxonidine: postmarketing
- mupirocin
- mycophenolate mofetil: 17.7% - 22.1%
- mycophenolic acid: postmarketing, 18% - 22.1%
- n-3 PUFA
- nabilone
- nabumetone: 7%
- nadolol
- nafcillin
- naftifine: postmarketing, 0.5%
- nalbuphine
- nalidixic acid
- naltrexone: postmarketing
- nandrolone decanoate
- naproxen: postmarketing
- naratriptan: rare, infrequent
- nateglinide: rare
- nebivolol: postmarketing, 0% - 1%
- nedocromil sodium
- nefazodone
- nelfinavir: postmarketing, common, 0% - 8%
- neostigmine: postmarketing
- nesiritide: postmarketing, 0% - 1%
- nevirapine: postmarketing, very common, 4% - 24%
- niacin: 0% - 5%
- nicardipine: 0.6% - 0.9%
- nicorandil: uncommon
- nicotine: 1.9%
- nifedipine: 2.3%
- nilotinib: 0% - 37%
- nilutamide
- nimodipine: 2.44%
- nisoldipine: 2%
- nitazoxanide
- nitrazepam
- nitrogen mustard
- nitroglycerin
- nitroprusside
- nizatidine: 1.9%
- norethisterone
- norfloxacin: postmarketing
- nortriptyline
- nystatin
- ofatumumab: 1% - 17%
- ofloxacin: 1%
- ogen
- olanzapine: postmarketing, rare, 2%
- olmesartan: postmarketing, uncommon
- olmesartan medoxomil
- olodaterol: 2.17%
- olopatadine: 0% - 1.34%
- olsalazine: 1.13% - 2.3%
- omeprazole: postmarketing, uncommon, 0% - 1.5%
- ondansetron
- orlistat: postmarketing, uncommon, 4.3%
- oseltamivir: postmarketing
- oxacillin
- oxaliplatin: common, very common, 0% - 5%
- oxaprozin
- oxazepam
- oxcarbazepine: very rare, postmarketing, common, 1.4% - 5.3%
- oxiconazole
- oxybutynin: postmarketing
- oxycodone
- oxytetracycline
- oxytocin injection: rare
- paclitaxel: postmarketing, rare, very common, 9% - 14%
- paliperidone
- palonosetron
- pamidronate: postmarketing, common
- pancuronium
- pantoprazole: postmarketing, uncommon, 0% - 2%
- papaverine
- paraldehyde
- parecoxib
- paricalcitol: postmarketing, 3.7% - 4%
- paroxetine: postmarketing, uncommon, common, frequent
- pazopanib
- pegaptanib
- pemetrexed: 0% - 22%
- penciclovir: 0% - 3.3%
- penicillin
- pentamidine
- pentobarbital
- pentosan polysulfate: 0% - 3%
- pentostatin: 26% - 43%
- pentoxifylline: postmarketing
- pergolide: frequent, 3.2%
- perhexiline
- perindopril
- perindopril erbumine: postmarketing
- perindoprilat: postmarketing
- permethrin
- phenelzine
- phenobarbital
- phentermine
- phenylazo
- phenylbutyric acid
- phenyllactate
- phenylpropanolamine
- phenytoin: frequent
- phosphate
- pilocarpine: 2%
- pimecrolimus: postmarketing, rare
- pimozide: postmarketing, 2.78% - 8.33%
- pindolol: 1%
- piperacillin: common
- pirbuterol: 0% - 1.3%
- pirfenidone
- piroxicam: 2.4%
- pitavastatin
- podophyllotoxin
- polythiazide
- pomalidomide: 16.1% - 21.5%
- ponatinib: 5% - 54%
- posaconazole: 1.72% - 15.1%
- potassium
- pralatrexate
- pramipexole: uncommon
- prasugrel: 2.4% - 2.8%
- pravastatin: 1.3% - 7.2%
- praziquantel
- prazosin
- prednicarbate
- prednisolone
- prednisolone acetate
- prednisolone phosphate
- prednisone
- pregabalin
- primidone
- procaine penicillin
- procarbazine
- progesterone
- proguanil
- promethazine
- propafenone: postmarketing, 0.6% - 3%
- propantheline
- propericiazine
- propofol
- propoxyphene
- propoxyphene napsylate
- propranolol: postmarketing
- propylthiouracil
- prostacyclin: 4% - 25%
- protriptyline
- pyrantel
- pyrazinamide
- pyridostigmine
- quetiapine: 4%
- quinapril
- quinaprilat
- quinidine: 5% - 11%
- rabeprazole
- raloxifene: 5.5%
- raltegravir: postmarketing
- raltitrexed: 13%
- ramipril: 1.4%
- ramiprilat
- ranitidine
- ranolazine: postmarketing
- rapamycin: common, 2% - 20%
- rasagiline: common, 3% - 6%
- rasburicase: 0% - 23.4%
- reboxetine: 1.18%
- regadenoson: postmarketing
- regorafenib
- remifentanil
- repaglinide
- rescinnamine
- reserpine
- retigabine
- retinoic acid: postmarketing, very common, 1% - 54%
- ribavirin: very common, 5% - 34%
- rifabutin: 4% - 11%
- rifampicin
- rifapentine
- rifaximin: postmarketing, 5%
- rilpivirine: 2.3% - 11%
- riluzole
- rimantadine
- rimonabant: postmarketing
- risedronate: rare, 7.9% - 11.5%
- risperidone: frequent, 0% - 11%
- ritonavir: 0% - 3.5%
- rivaroxaban
- rivastigmine: postmarketing, rare, infrequent, frequent
- rizatriptan: infrequent
- rocuronium
- rofecoxib
- roflumilast: postmarketing
- ropinirole: postmarketing, infrequent, frequent
- ropivacaine: 0.5% - 1.8%
- rosiglitazone: very rare, postmarketing
- rosuvastatin: uncommon
- rotigotine
- roxithromycin
- rufinamide: 2% - 4%
- salbutamol: postmarketing, 0% - 7.5%
- salicylate
- salmeterol: uncommon, 2% - 4%
- salmon calcitonin acetate: postmarketing
- salsalate
- samarium: 1.01%
- saquinavir: common
- scopolamine
- secobarbital
- sertraline: postmarketing, common, 3%
- sevelamer: postmarketing
- sevelamer carbonate: postmarketing
- sevelamer hydrochloride: postmarketing
- sevoflurane: postmarketing
- sibutramine
- sildenafil: postmarketing, uncommon, 1% - 2%
- silodosin: postmarketing
- silver nanoparticles
- silver sulfadiazine
- simvastatin: 0.6% - 0.7%
- sitagliptin: postmarketing
- sitaxsentan: rare
- sodium: postmarketing
- sodium cromoglycate
- sodium ferric gluconate
- sodium iodide
- sodium nitroprusside
- sofosbuvir: very common, 8% - 18%
- solifenacin: postmarketing
- sorafenib: postmarketing, 0% - 40%
- sotalol: 1% - 5%
- sparfloxacin: 1.1%
- spironolactone
- stavudine: common, 35% - 40%
- stiripentol
- streptomycin
- strontium ranelate: postmarketing
- succinylcholine
- sufentanil
- sulfadiazine
- sulfamethoxazole
- sulfasalazine: 13%
- sulindac
- sumatriptan: postmarketing, infrequent
- sunitinib: 1%
- tacrolimus: common, 1% - 24%
- tadalafil: postmarketing, 5%
- tamoxifen: postmarketing, 13% - 12.5%
- tamsulosin: postmarketing, uncommon, 1.8%
- tapentadol: 1%
- tazarotene: 1% - 3%
- technetium-99m
- tegaserod: postmarketing, 1%
- telavancin: common, 4% - 5%
- telithromycin
- telmisartan: postmarketing, rare, uncommon, common
- temozolomide: very rare, common, very common, 0% - 19.4%
- temsirolimus
- teniposide: 3%
- tenofovir: postmarketing, 5% - 9%
- tenofovir disoproxil fumarate: postmarketing, very common, 5% - 7%
- tenoxicam: uncommon
- terazosin: 1.7%
- terbinafine: common, 0.7% - 9%
- terbutaline
- terconazole: postmarketing
- tesamorelin: 3.7%
- testosterone: postmarketing, uncommon, common, 2%
- testosterone enanthate: postmarketing
- testosterone propionate
- testosterone undecanoate
- tetracycline
- tetraen
- tetrahydrobiopterin: postmarketing, 5.41%
- tetrofosmin: postmarketing
- thalidomide: 0% - 31.4%
- theophylline
- thiabendazole
- thiazide
- thiotepa: 1-10%
- thiothixene
- thymidine: 1% - 4%
- thyroxine
- tiagabine: 5%
- tiaprofenic acid: 1.7% - 7.2%
- tibolone
- ticagrelor
- ticlopidine
- tigecycline: common, 2.4% - 4.1%
- timolol
- tinidazole
- tiopronin
- tiotropium: 2% - 4%
- tipranavir: uncommon, common, 3.8% - 5.5%
- tizanidine: postmarketing, frequent
- tobramycin: rare, common, 2.3% - 5.4%
- tofacitinib
- tolcapone: frequent
- topiramate: very rare, postmarketing, 0.4% - 6.7%
- topotecan: common, 0% - 16%
- torasemide
- toremifene
- trabectedin
- tramadol: uncommon
- tramazoline
- trametinib: 0% - 57%
- trandolapril: postmarketing, 0.4% - 1.2%
- trandolaprilat
- trans 4-cyclohexyl-L-proline
- tranylcypromine
- travoprost: rare, uncommon
- trazodone: postmarketing
- treprostinil: postmarketing, 14%
- triamcinolone: postmarketing
- triamcinolone acetonide: postmarketing, 2.5%
- triamterene
- trifluoperazine
- trihexyphenidyl
- trimethadione
- trimethoprim: common, 1.3% - 6.1%
- trimethoprim-sulfamethoxazole: very rare, common
- trimetrexate: 2.75% - 12.6%
- trimipramine
- tropisetron: postmarketing
- trospium chloride: postmarketing
- trovafloxacin: 1% - 2%
- umeclidinium
- ustekinumab: postmarketing, uncommon, common
- v 1784: postmarketing, uncommon, common, 7% - 12%
- valdecoxib: 0.5% - 1.5%
- valproate: 2% - 6%
- valrubicin
- valsartan: very rare, 0.2% - 0.6%
- vandetanib: 0.4% - 53%
- vardenafil
- varenicline: 1% - 3%
- vecuronium
- vemurafenib: postmarketing, 0% - 52%
- venlafaxine: uncommon
- verapamil: postmarketing, 2.4%
- verteporfin
- vigabatrin: uncommon, 4% - 11%
- vincristine
- vinflunine
- vinorelbine: postmarketing, 5%
- vismodegib
- vorapaxar: 2.24%
- voriconazole: common, very common, 0.524% - 6.63%
- warfarin
- x M22
- zafirlukast
- zalcitabine
- zaleplon: frequent
- zanamivir: postmarketing
- ziconotide
- zidovudine: postmarketing, uncommon, 12% - 17%
- zidovudine/lamivudine
- zileuton
- ziprasidone: postmarketing, uncommon, 1% - 4%
- zoledronic acid: uncommon, 2% - 3%
- zolmitriptan: infrequent
- zolpidem: postmarketing, rare, frequent, 1% - 2%
- zonisamide: 3%
- zopiclone: 3% - 4%
- zuclopenthixol
|
Drugs with this indication
|
